Valve-sparing aortic root replacement (VSARR) has become an appealing choice for replacing
an aneurysmal root when the patient's anatomic characteristics are favorable, especially
in patients with heritable thoracic aortic disease. It is a technically challenging
procedure, and the learning curve is considerable. This approach's chief advantages
are that the patient's own aortic valve apparatus is preserved, the repair (in expert
hands) is durable, and it avoids the need for lifelong anticoagulation associated
with the mechanical valves in the aortic root prostheses. In this report, we provide
a step-by-step approach for aortic root replacement in patients with a tricuspid aortic
valve suitable for VSARR.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Operative Techniques in Thoracic and Cardiovascular SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta.J Thorac Cardiovasc Surg. 1992; 103: 617-621
- Reimplantation of the aortic valve at 20 years.J Thorac Cardiovasc Surg. 2017; 153: 232-238
- Remodeling of the aortic valve anulus.J Thorac Cardiovasc Surg. 1993; 105: 435-438
- Aortic flow after valve sparing root replacement with or without neosinuses reconstruction.J Thorac Cardiovasc Surg. 2019; 157: 455-465
- Improvement in the assessment of aortic valve and aortic aneurysm repair by 3-dimensional echocardiography.JACC Cardiovasc Imaging. 2019; 12: 2225-2244
- Preoperative aortic root geometry and postoperative cusp configuration primarily determine long-term outcome after valve-preserving aortic root repair.J Thorac Cardiovasc Surg. 2012; 143: 1389-1395
- Valve-sparing versus valve-replacing aortic root operations in patients with Marfan syndrome.Shanghai Chest. 2020; 4
- Aortic root replacement in 372 Marfan patients: evolution of operative repair over 30 years.Ann Thorac Surg. 2009; 87: 1344-1349
- Replacement of the aortic root in patients with Marfan's syndrome.N Engl J Med. 1999; 340: 1307-1313
- Valve-sparing and valve-replacing techniques for aortic root replacement in patients with Marfan syndrome: Analysis of early outcome.J Thorac Cardiovasc Surg. 2009; 137: 1124-1132
- A quarter of a century of experience with aortic valve-sparing operations.J Thorac Cardiovasc Surg. 2014; 148: 872-879
- Aortic valve-sparing root replacement with Tirone E. David's reimplantation technique: single-centre 25-year experience.Eur J Cardiothorac Surg. 2021; 60: 642-648
- Valve-sparing aortic root replacement: early and midterm outcomes in 83 patients.Ann Thorac Surg. 2014; 97: 1267-1273
- Superior long-term survival after aortic valve-sparing root surgery in patients with connective tissue disorder.Structural Heart. 2021; 5: 12
- Long-term results of aortic valve-sparing operations for aortic root aneurysm.J Thorac Cardiovasc Surg. 2006; 132: 347-354
- Valve-sparing aortic root replacement: early experience with the De Paulis Valsalva graft in 51 patients.Ann Thorac Surg. 2006; 82: 548-553
Article info
Publication history
Published online: December 10, 2022
Publication stage
In Press Journal Pre-ProofFootnotes
Funding:This work was not directly funded. An endowment from the Cullen Foundation (for Dr. Coselli) provided partial support.
Conflicts of Interest: Dr. Coselli serves as principal investigator, consults for, and receives royalties and a departmental educational grant from Terumo Aortic; consults and participates in clinical trials for Medtronic, Inc., W.L. Gore & Associates, and Abbott Laboratories; and participates in clinical trials for CytoSorbents, Edwards Lifesciences, and Artivion. Dr. Preventza is a consultant for Terumo Aortic and W. L. Gore & Associates. Dr. Le Huu has no conflicts of interest to report.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
